Immune cells protect and heal the human body. In medicine, they are specifically activated through biochemical reactions to ...
The CancerVax platform is designed to harness the body’s existing immunity to detect, mark, and kill cancer cells with ...
T cells lie at the heart of adaptive immunity, recognising peptide antigens via the T cell receptor (TCR) and undergoing activation only when signals from co-stimulatory receptors complement antigen ...
Every encounter between a T cell and a potential target—especially when that target is a developing tumor—begins with a rapid ...
Bristol Myers Squibb hasn’t had much luck with its efforts to develop cancer treatments called T cell engagers. But the pharmaceutical company isn’t done pursuing this type of targeted cancer therapy, ...
A study suggests that exhausted T cells may be burning energy too aggressively rather than simply running out of it.
(A) CuN is formed by self-assembly of Cu²⁺ and NLG919 via Cu-N coordination bonds, with chemotherapeutic agents (e.g., β-lapachone) encapsulated through hydrophobic interactions. (B) Lap@CuN passively ...
Durable reprogramming of human T cells may now be possible thanks to a new technique based on the CRISPRoff and CRISPRon methodology. Researchers from the Arc Institute, Gladstone Institutes, and the ...
Why do immune cells that are supposed to eliminate viruses suddenly turn against our own body? There are instances where killer T cells—which are meant to precisely remove virus-infected ...
A new study published in Science identifies a specialised dendritic cell subset as the cellular architects behind tertiary ...
Researchers at the Keck School of Medicine of University of Southern California (USC) have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results